- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ATL loses appeal on SRI lawsuit
ATL Ultrasound announced last month that the U.S. Court of Appeals affirmed a lower court decision in the patent litigation filed against the Bothell, WA-based vendor by SRI International. ATL does not plan to appeal further, which brings the case to a
ATL Ultrasound announced last month that the U.S. Court of Appeals affirmed a lower court decision in the patent litigation filed against the Bothell, WA-based vendor by SRI International. ATL does not plan to appeal further, which brings the case to a close. The company has already set aside $37.1 million in prior financial periods to cover the full cost of the judgment, which was awarded in 1996 (SCAN 6/5/96). SRI filed the suit in 1991, charging ATL with violating a patent SRI received in 1977 for tracking filter circuits used in ATL's Ultramark 4, Ultramark 5, and ADR 4000 ultrasound scanners, all of which have been discontinued. The relevant patent expired in 1994, according to ATL.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
